Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $12.08 USD
Change Today -0.24 / -1.95%
Volume 211.4K
AGRX On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

agile therapeutics inc (AGRX) Snapshot

Open
$12.32
Previous Close
$12.32
Day High
$12.33
Day Low
$11.75
52 Week High
04/16/15 - $13.19
52 Week Low
05/23/14 - $5.05
Market Cap
267.6M
Average Volume 10 Days
152.3K
EPS TTM
--
Shares Outstanding
22.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AGILE THERAPEUTICS INC (AGRX)

Related News

No related news articles were found.

agile therapeutics inc (AGRX) Related Businessweek News

No Related Businessweek News Found

agile therapeutics inc (AGRX) Details

Agile Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, a once-weekly contraceptive patch, which is in Phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, a 28-day regimen, which provides a shortened hormone-free interval; and AG890, a progestin-only contraceptive patch for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.

14 Employees
Last Reported Date: 03/26/15
Founded in 1997

agile therapeutics inc (AGRX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $390.0K
Chief Financial Officer and Vice President
Total Annual Compensation: $270.0K
Compensation as of Fiscal Year 2013.

agile therapeutics inc (AGRX) Key Developments

Agile Therapeutics, Inc. Announces Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

Agile Therapeutics, Inc. announced unaudited earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported loss from operations of $6,524,000 against $1,930,000 a year ago. Loss before benefit from income taxes was $6,845,000 against $2,404,000 a year ago. Net loss was $6,845,000 or $0.37 per basic and diluted share against $2,404,000 or $45.68 per basic and diluted share a year ago. For the year, the company reported loss from operations of $18,515,000 against $12,728,000 a year ago. Loss before benefit from income taxes was $19,730,000 against $14,320,000 a year ago. Net loss was $16,077,000 or $1.41 per basic and diluted share against $14,320,000 or $289.39 per basic and diluted share a year ago.

Agile Therapeutics, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-15-2015 04:20 PM

Agile Therapeutics, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-15-2015 04:20 PM. Venue: Westin Grand Central Hotel, New York, New York, United States. Speakers: Alfred F. Altomari, Chief Executive Officer, President and Director.

Agile Therapeutics, Inc. Presents at 27th Annual ROTH Conference, Mar-09-2015 04:30 PM

Agile Therapeutics, Inc. Presents at 27th Annual ROTH Conference, Mar-09-2015 04:30 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States. Speakers: Alfred F. Altomari, Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGRX:US $12.08 USD -0.24

AGRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AGRX.
View Industry Companies
 

Industry Analysis

AGRX

Industry Average

Valuation AGRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 6.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGILE THERAPEUTICS INC, please visit www.agiletherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.